Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.

Standard

Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. / Brähler, Sebastian; Ising, Christina; Hagmann, Henning; Rasmus, Melanie; Hoehne, Martin; Kurschat, Christine; Kisner, Tuelay; Goebel, Heike; Shankland, Stuart; Addicks, Klaus; Thaiss, Friedrich; Schermer, Bernhard; Pasparakis, Manolis; Benzing, Thomas; Brinkkoetter, Paul Thomas.

in: AM J PHYSIOL-RENAL, Jahrgang 303, Nr. 10, 10, 2012, S. 1473-1485.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Brähler, S, Ising, C, Hagmann, H, Rasmus, M, Hoehne, M, Kurschat, C, Kisner, T, Goebel, H, Shankland, S, Addicks, K, Thaiss, F, Schermer, B, Pasparakis, M, Benzing, T & Brinkkoetter, PT 2012, 'Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.', AM J PHYSIOL-RENAL, Jg. 303, Nr. 10, 10, S. 1473-1485. <http://www.ncbi.nlm.nih.gov/pubmed/22975019?dopt=Citation>

APA

Brähler, S., Ising, C., Hagmann, H., Rasmus, M., Hoehne, M., Kurschat, C., Kisner, T., Goebel, H., Shankland, S., Addicks, K., Thaiss, F., Schermer, B., Pasparakis, M., Benzing, T., & Brinkkoetter, P. T. (2012). Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. AM J PHYSIOL-RENAL, 303(10), 1473-1485. [10]. http://www.ncbi.nlm.nih.gov/pubmed/22975019?dopt=Citation

Vancouver

Brähler S, Ising C, Hagmann H, Rasmus M, Hoehne M, Kurschat C et al. Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. AM J PHYSIOL-RENAL. 2012;303(10):1473-1485. 10.

Bibtex

@article{b3d06dcaf5ae41e2bde7bc4a58bb0dc0,
title = "Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.",
abstract = "Inflammation conveys the development of glomerular injury and is a major cause of progressive kidney disease. NF-?B signaling is among the most important regulators of proinflammatory signaling. Its role in podocytes, the epithelial cells at the kidney filtration barrier, is poorly understood. Here, we inhibited NF-?B signaling in podocytes by specific ablation of the NF-?B essential modulator (NEMO, IKK?). Podocyte-specific NEMO-deficient mice (NEMO(pko)) were viable and did not show proteinuria or overt changes in kidney morphology. After induction of glomerulonephritis, both NEMO(pko) and control mice developed significant proteinuria. However, NEMO(pko) mice recovered much faster, showing rapid remission of proteinuria and restoration of podocyte morphology. Interestingly, quantification of infiltrating macrophages, T-lymphocytes, and granulocytes at day 7 revealed no significant difference between wild-type and NEMO(pko). To further investigate the underlying mechanisms, we created a stable NEMO knockdown mouse podocyte cell line. Again, no overt changes in morphology were observed. Translocation of NF-?B to the nucleus after stimulation with TNF? or IL-1 was sufficiently inhibited. Moreover, secretion of proinflammatory chemokines from podocytes after stimulation with TNF? or IL-1 was significantly reduced in NEMO-deficient podocytes and in glomerular samples obtained at day 7 after induction of nephrotoxic nephritis. Collectively, these results show that proinflammatory activity of NF-?B in podocytes aggravates proteinuria in experimental glomerulonephritis in mice. Based on these data, it may be speculated that immunosuppressive drugs may not only target professional immune cells but also podocytes directly to convey their beneficial effects in various types of glomerulonephritis.",
keywords = "Animals, Humans, Disease Models, Animal, Mice, Mice, Knockout, HEK293 Cells, RNA Interference, NF-kappa B/*metabolism, Tumor Necrosis Factor-alpha/pharmacology, Interleukin-1/pharmacology, Signal Transduction/drug effects/*physiology, Glomerulonephritis/*metabolism/pathology, I-kappa B Kinase/genetics/metabolism, Inflammation/metabolism/pathology, Macrophages/metabolism/pathology, Podocytes/drug effects/*metabolism/pathology, Proteinuria/*metabolism/pathology, T-Lymphocytes/metabolism/pathology, Animals, Humans, Disease Models, Animal, Mice, Mice, Knockout, HEK293 Cells, RNA Interference, NF-kappa B/*metabolism, Tumor Necrosis Factor-alpha/pharmacology, Interleukin-1/pharmacology, Signal Transduction/drug effects/*physiology, Glomerulonephritis/*metabolism/pathology, I-kappa B Kinase/genetics/metabolism, Inflammation/metabolism/pathology, Macrophages/metabolism/pathology, Podocytes/drug effects/*metabolism/pathology, Proteinuria/*metabolism/pathology, T-Lymphocytes/metabolism/pathology",
author = "Sebastian Br{\"a}hler and Christina Ising and Henning Hagmann and Melanie Rasmus and Martin Hoehne and Christine Kurschat and Tuelay Kisner and Heike Goebel and Stuart Shankland and Klaus Addicks and Friedrich Thaiss and Bernhard Schermer and Manolis Pasparakis and Thomas Benzing and Brinkkoetter, {Paul Thomas}",
year = "2012",
language = "English",
volume = "303",
pages = "1473--1485",
journal = "AM J PHYSIOL-RENAL",
issn = "1931-857X",
publisher = "AMER PHYSIOLOGICAL SOC",
number = "10",

}

RIS

TY - JOUR

T1 - Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria.

AU - Brähler, Sebastian

AU - Ising, Christina

AU - Hagmann, Henning

AU - Rasmus, Melanie

AU - Hoehne, Martin

AU - Kurschat, Christine

AU - Kisner, Tuelay

AU - Goebel, Heike

AU - Shankland, Stuart

AU - Addicks, Klaus

AU - Thaiss, Friedrich

AU - Schermer, Bernhard

AU - Pasparakis, Manolis

AU - Benzing, Thomas

AU - Brinkkoetter, Paul Thomas

PY - 2012

Y1 - 2012

N2 - Inflammation conveys the development of glomerular injury and is a major cause of progressive kidney disease. NF-?B signaling is among the most important regulators of proinflammatory signaling. Its role in podocytes, the epithelial cells at the kidney filtration barrier, is poorly understood. Here, we inhibited NF-?B signaling in podocytes by specific ablation of the NF-?B essential modulator (NEMO, IKK?). Podocyte-specific NEMO-deficient mice (NEMO(pko)) were viable and did not show proteinuria or overt changes in kidney morphology. After induction of glomerulonephritis, both NEMO(pko) and control mice developed significant proteinuria. However, NEMO(pko) mice recovered much faster, showing rapid remission of proteinuria and restoration of podocyte morphology. Interestingly, quantification of infiltrating macrophages, T-lymphocytes, and granulocytes at day 7 revealed no significant difference between wild-type and NEMO(pko). To further investigate the underlying mechanisms, we created a stable NEMO knockdown mouse podocyte cell line. Again, no overt changes in morphology were observed. Translocation of NF-?B to the nucleus after stimulation with TNF? or IL-1 was sufficiently inhibited. Moreover, secretion of proinflammatory chemokines from podocytes after stimulation with TNF? or IL-1 was significantly reduced in NEMO-deficient podocytes and in glomerular samples obtained at day 7 after induction of nephrotoxic nephritis. Collectively, these results show that proinflammatory activity of NF-?B in podocytes aggravates proteinuria in experimental glomerulonephritis in mice. Based on these data, it may be speculated that immunosuppressive drugs may not only target professional immune cells but also podocytes directly to convey their beneficial effects in various types of glomerulonephritis.

AB - Inflammation conveys the development of glomerular injury and is a major cause of progressive kidney disease. NF-?B signaling is among the most important regulators of proinflammatory signaling. Its role in podocytes, the epithelial cells at the kidney filtration barrier, is poorly understood. Here, we inhibited NF-?B signaling in podocytes by specific ablation of the NF-?B essential modulator (NEMO, IKK?). Podocyte-specific NEMO-deficient mice (NEMO(pko)) were viable and did not show proteinuria or overt changes in kidney morphology. After induction of glomerulonephritis, both NEMO(pko) and control mice developed significant proteinuria. However, NEMO(pko) mice recovered much faster, showing rapid remission of proteinuria and restoration of podocyte morphology. Interestingly, quantification of infiltrating macrophages, T-lymphocytes, and granulocytes at day 7 revealed no significant difference between wild-type and NEMO(pko). To further investigate the underlying mechanisms, we created a stable NEMO knockdown mouse podocyte cell line. Again, no overt changes in morphology were observed. Translocation of NF-?B to the nucleus after stimulation with TNF? or IL-1 was sufficiently inhibited. Moreover, secretion of proinflammatory chemokines from podocytes after stimulation with TNF? or IL-1 was significantly reduced in NEMO-deficient podocytes and in glomerular samples obtained at day 7 after induction of nephrotoxic nephritis. Collectively, these results show that proinflammatory activity of NF-?B in podocytes aggravates proteinuria in experimental glomerulonephritis in mice. Based on these data, it may be speculated that immunosuppressive drugs may not only target professional immune cells but also podocytes directly to convey their beneficial effects in various types of glomerulonephritis.

KW - Animals

KW - Humans

KW - Disease Models, Animal

KW - Mice

KW - Mice, Knockout

KW - HEK293 Cells

KW - RNA Interference

KW - NF-kappa B/metabolism

KW - Tumor Necrosis Factor-alpha/pharmacology

KW - Interleukin-1/pharmacology

KW - Signal Transduction/drug effects/physiology

KW - Glomerulonephritis/metabolism/pathology

KW - I-kappa B Kinase/genetics/metabolism

KW - Inflammation/metabolism/pathology

KW - Macrophages/metabolism/pathology

KW - Podocytes/drug effects/metabolism/pathology

KW - Proteinuria/metabolism/pathology

KW - T-Lymphocytes/metabolism/pathology

KW - Animals

KW - Humans

KW - Disease Models, Animal

KW - Mice

KW - Mice, Knockout

KW - HEK293 Cells

KW - RNA Interference

KW - NF-kappa B/metabolism

KW - Tumor Necrosis Factor-alpha/pharmacology

KW - Interleukin-1/pharmacology

KW - Signal Transduction/drug effects/physiology

KW - Glomerulonephritis/metabolism/pathology

KW - I-kappa B Kinase/genetics/metabolism

KW - Inflammation/metabolism/pathology

KW - Macrophages/metabolism/pathology

KW - Podocytes/drug effects/metabolism/pathology

KW - Proteinuria/metabolism/pathology

KW - T-Lymphocytes/metabolism/pathology

M3 - SCORING: Journal article

VL - 303

SP - 1473

EP - 1485

JO - AM J PHYSIOL-RENAL

JF - AM J PHYSIOL-RENAL

SN - 1931-857X

IS - 10

M1 - 10

ER -